Heart Failure POC & LOC Devices Market by Test Type (Genomic Testing, Metabolomic Testing, Proteomic Testing), Technology (Array-based Systems, Microfluidics), End-user - Global Forecast 2024-2030

Heart Failure POC & LOC Devices Market by Test Type (Genomic Testing, Metabolomic Testing, Proteomic Testing), Technology (Array-based Systems, Microfluidics), End-user - Global Forecast 2024-2030


The Heart Failure POC & LOC Devices Market size was estimated at USD 88.49 million in 2023 and expected to reach USD 105.47 million in 2024, at a CAGR 19.66% to reach USD 310.93 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Heart Failure POC & LOC Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Heart Failure POC & LOC Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Heart Failure POC & LOC Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories Inc., ACON Laboratories Inc, Amgen Inc., AstraZeneca PLC, Becton, Dickinson & Company, bioMérieux S.A., Boditech Med Inc., Dolphin Corporation, Dr. Reddy's Laboratories Ltd., F. Hoffmann-La Roche Ltd., Jant Pharmacal Corporation, Medtronic PLC, Novartis AG, Samsung Electronics Co. Ltd., and Sanofi S.A..

Market Segmentation & Coverage



This research report categorizes the Heart Failure POC & LOC Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

Test Type
Genomic Testing
Metabolomic Testing
Proteomic Testing
Technology
Array-based Systems
Microfluidics
End-user
Assisted Living Healthcare Facilities
Clinics
Home
Hospitals
Laboratory
Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas
Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam
Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Heart Failure POC & LOC Devices Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Heart Failure POC & LOC Devices Market?
3. What are the technology trends and regulatory frameworks in the Heart Failure POC & LOC Devices Market?
4. What is the market share of the leading vendors in the Heart Failure POC & LOC Devices Market?
5. Which modes and strategic moves are suitable for entering the Heart Failure POC & LOC Devices Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Heart Failure POC & LOC Devices Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing need for early diagnosis of diseases to reduce healthcare costs
5.1.1.2. Growing development of disposable and low-cost LOC devices with sensors and other accessories
5.1.1.3. Rising adoption of POC and LOC devices by governments to alleviate the rising healthcare expenditure
5.1.2. Restraints
5.1.2.1. Lack of standard reimbursement for POC devices with a cartridge that performs multiple tests
5.1.3. Opportunities
5.1.3.1. Advancements in technology to increase research activities for the identification of novel biomarkers
5.1.3.2. Emerging development of predictive-modeling techniques to analyze the LOC assays data for therapy monitoring
5.1.4. Challenges
5.1.4.1. Reduced accessibility and awareness among the population
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Heart Failure POC & LOC Devices Market, by Test Type
6.1. Introduction
6.2. Genomic Testing
6.3. Metabolomic Testing
6.4. Proteomic Testing
7. Heart Failure POC & LOC Devices Market, by Technology
7.1. Introduction
7.2. Array-based Systems
7.3. Microfluidics
8. Heart Failure POC & LOC Devices Market, by End-user
8.1. Introduction
8.2. Assisted Living Healthcare Facilities
8.3. Clinics
8.4. Home
8.5. Hospitals
8.6. Laboratory
9. Americas Heart Failure POC & LOC Devices Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Heart Failure POC & LOC Devices Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Heart Failure POC & LOC Devices Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Abbott Laboratories Inc.
13.1.2. ACON Laboratories Inc
13.1.3. Amgen Inc.
13.1.4. AstraZeneca PLC
13.1.5. Becton, Dickinson & Company
13.1.6. bioMérieux S.A.
13.1.7. Boditech Med Inc.
13.1.8. Dolphin Corporation
13.1.9. Dr. Reddy's Laboratories Ltd.
13.1.10. F. Hoffmann-La Roche Ltd.
13.1.11. Jant Pharmacal Corporation
13.1.12. Medtronic PLC
13.1.13. Novartis AG
13.1.14. Samsung Electronics Co. Ltd.
13.1.15. Sanofi S.A.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
FIGURE 1. HEART FAILURE POC & LOC DEVICES MARKET RESEARCH PROCESS
FIGURE 2. HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2023 VS 2030
FIGURE 3. HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. HEART FAILURE POC & LOC DEVICES MARKET DYNAMICS
FIGURE 7. HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
FIGURE 8. HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 10. HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. HEART FAILURE POC & LOC DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. HEART FAILURE POC & LOC DEVICES MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings